Carson K. L. Lo

2.9k total citations · 2 hit papers
25 papers, 2.1k citations indexed

About

Carson K. L. Lo is a scholar working on Infectious Diseases, Statistics, Probability and Uncertainty and Epidemiology. According to data from OpenAlex, Carson K. L. Lo has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Statistics, Probability and Uncertainty and 6 papers in Epidemiology. Recurrent topics in Carson K. L. Lo's work include Meta-analysis and systematic reviews (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Statistical Methods in Clinical Trials (6 papers). Carson K. L. Lo is often cited by papers focused on Meta-analysis and systematic reviews (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Statistical Methods in Clinical Trials (6 papers). Carson K. L. Lo collaborates with scholars based in Canada, United States and Australia. Carson K. L. Lo's co-authors include Mark Loeb, Dominik Mertz, Adam S. Komorowski, Anthony D. Bai, Pranav Tandon, Julien Senécal, Andrew M. Morris, Olivier Del Corpo, Emily G. McDonald and Akhil Garg and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Carson K. L. Lo

23 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments

2014 1.8k citations Carson K. L. Lo, Dominik Mertz et al. BMC Medical Research Methodology profile →
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis

2022 150 citations Anthony D. Bai, Carson K. L. Lo et al. Clinical Microbiology and Infection profile →

Peers

Carson K. L. Lo

SURGE

EPIDE

PRM

PHEOH

David Lora Spain

Stella Leung Canada

Ana Royuela Spain

Christopher E. Dandoy United States

Glen Hazlewood Canada

Nina Kohn United States

Sourya Acharya India

Fredrik Granath Sweden

R. M. Pandey India

Necdet Süt Türkiye

David Lora Spain

Carson K. L. Lo

359 ×0.8

SURGE

676 ×1.8

EPIDE

439 ×1.4

PRM

182 ×0.8

242 ×1.1

PHEOH

Citations per year, relative to Carson K. L. Lo Carson K. L. Lo (= 1×) peers David Lora

Countries citing papers authored by Carson K. L. Lo

Since Specialization

Citations

This map shows the geographic impact of Carson K. L. Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carson K. L. Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carson K. L. Lo more than expected).

Fields of papers citing papers by Carson K. L. Lo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carson K. L. Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carson K. L. Lo. The network helps show where Carson K. L. Lo may publish in the future.

Co-authorship network of co-authors of Carson K. L. Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Carson K. L. Lo. A scholar is included among the top collaborators of Carson K. L. Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carson K. L. Lo. Carson K. L. Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rotstein, Coleman, et al.. (2025). Holy water not so holy: Potential source of Elizabethkingia pneumonia and bacteremia in an immunocompromised host. IDCases. 40. e02230–e02230.

Bai, Anthony D., et al.. (2023). Comparison of Preprint Postings of Randomized Clinical Trials on COVID-19 and Corresponding Published Journal Articles. JAMA Network Open. 6(1). e2253301–e2253301. 3 indexed citations

Lo, Carson K. L., Adam S. Komorowski, Clayton W. Hall, et al.. (2023). Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review. Clinical Infectious Diseases. 77(7). 1023–1031. 4 indexed citations

Lo, Carson K. L. & Deepali Kumar. (2023). Respiratory viral infections including COVID-19 in solid organ transplantation. Current Opinion in Organ Transplantation. 28(6). 471–482. 2 indexed citations

Komorowski, Adam S., Carson K. L. Lo, Marek Smieja, et al.. (2023). More Than a Decade Since the Latest CONSORT Non-inferiority Trials Extension: Do Infectious Diseases Trials Do Enough?. Clinical Infectious Diseases. 78(2). 324–329. 1 indexed citations

Bartoszko, Jessica, et al.. (2022). Prognostic factors for streptococcal toxic shock syndrome: systematic review and meta-analysis. BMJ Open. 12(12). e063023–e063023. 11 indexed citations

Bai, Anthony D., Carson K. L. Lo, Adam S. Komorowski, et al.. (2022). Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clinical Microbiology and Infection. 28(8). 1076–1084. 150 indexed citations breakdown →

Bai, Anthony D., Carson K. L. Lo, Adam S. Komorowski, et al.. (2022). How Generalizable Are Randomized Controlled Trials (RCTs) in Staphylococcus aureus Bacteremia? A Description of the Mortality Gap Between RCTs and Observational Studies. Clinical Infectious Diseases. 75(8). 1449–1452. 10 indexed citations

Bai, Anthony D., Carson K. L. Lo, Adam S. Komorowski, et al.. (2022). Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review. International Journal of Infectious Diseases. 122. 405–411. 16 indexed citations

10.

Komorowski, Adam S., Anthony D. Bai, Carson K. L. Lo, et al.. (2022). Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?. PubMed. 66(1). e0162721–e0162721. 1 indexed citations

11.

Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2021). Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review. BMC Medical Research Methodology. 21(1). 75–75. 21 indexed citations

12.

Lo, Carson K. L. & Prameet M. Sheth. (2021). Carnobacterium inhibens isolated in blood culture of an immunocompromised, metastatic cancer patient: a case report and literature review. BMC Infectious Diseases. 21(1). 403–403. 9 indexed citations

13.

Komorowski, Adam S., et al.. (2021). Meningitis caused by Mycobacterium tuberculosis in a recent immigrant to Canada. Canadian Medical Association Journal. 193(47). E1807–E1810. 2 indexed citations

14.

Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2021). Confidence interval of risk difference by different statistical methods and its impact on the study conclusion in antibiotic non-inferiority trials. Trials. 22(1). 708–708. 2 indexed citations

15.

Komorowski, Adam S., Anthony D. Bai, Carson K. L. Lo, et al.. (2021). Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?. Antimicrobial Agents and Chemotherapy. 66(1). 4 indexed citations

16.

Komorowski, Adam S., Anthony D. Bai, Carson K. L. Lo, et al.. (2021). Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic review. Clinical Microbiology and Infection. 28(5). 640–648. 8 indexed citations

17.

Lo, Carson K. L., et al.. (2021). Management of Mycobacterium tuberculosis Prosthetic Joint Infection: 2 Cases and Literature Review. Open Forum Infectious Diseases. 8(10). 9 indexed citations

18.

Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2020). Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antibiotic Therapies: A Systematic Review. Clinical Infectious Diseases. 73(7). e1696–e1705. 11 indexed citations

19.

Wang, Michael Ke, Benjamin Chin‐Yee, Carson K. L. Lo, et al.. (2019). Crusted scabies in a renal transplant recipient treated with daily ivermectin: A case report and literature review. Transplant Infectious Disease. 21(3). e13077–e13077. 8 indexed citations

20.

Lo, Carson K. L., Dominik Mertz, & Mark Loeb. (2014). Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Medical Research Methodology. 14(1). 45–45. 1780 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact